Dipivefrin (hydrochloride) |
Katalog-Nr.GC43476 |
Dipivefrin (Hydrochlorid) (Dipivefrin-Hydrochlorid) ist ein Antiglaukom-Prodrug, das durch Esterasen in der Hornhaut zum Wirkstoff Epinephrin hydrolysiert wird.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 64019-93-8
Sample solution is provided at 25 µL, 10mM.
Dipivefrin is a prodrug of epinephrine that is hydrolyzed by cholinesterase and other esterases in the cornea to epinephrine. It reduces the density of cultured bovine primary trabecular meshwork cells (IC50 = 115 µM). Additionally, it induces an elongated, fibroblast-like morphology and disrupts the actin cytoskeleton in bovine primary trabecular meshwork cells when used at a concentration of 103 µM. In cultured bovine corneal endothelial cells, dipivefrin (28 µM) enhances calcium signaling and induces cytotoxicity. Dipivefrin also suppresses primary human corneal keratinocyte proliferation when used at a concentration of 280 µM. Formulations containing dipivefrin have been used alone and in combination with β-adrenergic receptor antagonists for the treatment of glaucoma.
Average Rating: 5
(Based on Reviews and 25 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *